What's in LitePharmTech Co., Ltd.'s pipeline?

LitePharmTech Co., Ltd. has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with LitePharmTech Co., Ltd.'s portfolio?

Top competitors by shared drug class: Abant Izzet Baysal University, Beijing Tongren Hospital, Erasmus Medical Center, Massachusetts Eye and Ear Infirmary, Oupushifang Pharmaceutical Technology Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/litepharmtech-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

LitePharmTech Co., Ltd. — Portfolio Competitive Intelligence Brief

LitePharmTech Co., Ltd. pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Atropine Sulfate 02	Atropine Sulfate 02	phase 3	Anticholinergic agent / Muscarinic receptor antagonist	Muscarinic acetylcholine receptors (M1-M5)	Emergency Medicine, Ophthalmology, Cardiology
Atropine Sulfate 03	Atropine Sulfate 03	phase 3	Anticholinergic agent / Muscarinic antagonist	Muscarinic acetylcholine receptors (M1-M5)	Emergency Medicine, Ophthalmology, Cardiology
Atropine Sulfate 01	Atropine Sulfate 01	phase 3	Anticholinergic agent / Muscarinic antagonist	Muscarinic acetylcholine receptors (M1-M5)	Emergency Medicine, Anesthesia, Ophthalmology, Toxicology

Therapeutic area mix

Emergency Medicine, Ophthalmology, Cardiology · 2
Emergency Medicine, Anesthesia, Ophthalmology, Toxicology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abant Izzet Baysal University · 1 shared drug class
Beijing Tongren Hospital · 1 shared drug class
Erasmus Medical Center · 1 shared drug class
Massachusetts Eye and Ear Infirmary · 1 shared drug class
Oupushifang Pharmaceutical Technology Co., Ltd. · 1 shared drug class
Shanghai Eye Disease Prevention and Treatment Center · 1 shared drug class
State University of New York College of Optometry · 1 shared drug class
University Hospital, Strasbourg, France · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for LitePharmTech Co., Ltd.:

Cite this brief

Drug Landscape (2026). LitePharmTech Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/litepharmtech-co-ltd. Accessed 2026-05-16.